Avricore Health (TSE:AVCR) has released an update.
Avricore Health has reported an 84% year-over-year revenue growth in the first half of 2024, with a significant increase in net profitability, marking their second consecutive profitable quarter. The company’s CEO attributes this success to their mission-driven approach and their HealthTab™ system deployments. With a strong working capital position, Avricore Health is well-equipped to sustain its growth and explore further market opportunities both in Canada and internationally.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
